965 related articles for article (PubMed ID: 11817980)
41. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
Diener HC; Jansen JP; Reches A; Pascual J; Pitei D; Steiner TJ;
Eur Neurol; 2002; 47(2):99-107. PubMed ID: 11844898
[TBL] [Abstract][Full Text] [Related]
42. Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan.
Colman SS; Brod MI; Krishnamurthy A; Rowland CR; Jirgens KJ; Gomez-Mancilla B
Clin Ther; 2001 Jan; 23(1):127-45. PubMed ID: 11219473
[TBL] [Abstract][Full Text] [Related]
43. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
[TBL] [Abstract][Full Text] [Related]
44. Spotlight on eletriptan in migraine.
McCormack PL; Keating GM
CNS Drugs; 2006; 20(11):961-4. PubMed ID: 17044732
[TBL] [Abstract][Full Text] [Related]
45. Oral sumatriptan for acute migraine.
McCrory DC; Gray RN
Cochrane Database Syst Rev; 2003; (3):CD002915. PubMed ID: 12917936
[TBL] [Abstract][Full Text] [Related]
46. Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better.
Pascual J; Cabarrocas X
Headache; 2002 Jan; 42(1):28-31. PubMed ID: 12005272
[TBL] [Abstract][Full Text] [Related]
47. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
[TBL] [Abstract][Full Text] [Related]
48. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
[TBL] [Abstract][Full Text] [Related]
49. Drugs for the acute treatment of migraine in children and adolescents.
Richer L; Billinghurst L; Linsdell MA; Russell K; Vandermeer B; Crumley ET; Durec T; Klassen TP; Hartling L
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD005220. PubMed ID: 27091010
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.
Lampl C; Voelker M; Diener HC
J Neurol; 2007 Jun; 254(6):705-12. PubMed ID: 17406776
[TBL] [Abstract][Full Text] [Related]
51. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.
Pascual J; Mateos V; Roig C; Sanchez-Del-Rio M; Jiménez D
Headache; 2007 Sep; 47(8):1152-68. PubMed ID: 17883520
[TBL] [Abstract][Full Text] [Related]
52. Eletriptan.
Gawel MJ; Grujich NN
Expert Opin Investig Drugs; 2001 Oct; 10(10):1869-74. PubMed ID: 11772292
[TBL] [Abstract][Full Text] [Related]
53. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan.
Géraud G; Spierings EL; Keywood C
Headache; 2002 Apr; 42 Suppl 2():S93-9. PubMed ID: 12028325
[TBL] [Abstract][Full Text] [Related]
54. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
[TBL] [Abstract][Full Text] [Related]
55. Naratriptan: an alternative for migraine.
Dulli DA
Ann Pharmacother; 1999 Jun; 33(6):704-11. PubMed ID: 10410185
[TBL] [Abstract][Full Text] [Related]
56. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.
Ashcroft DM; Millson D
Pharmacoepidemiol Drug Saf; 2004 Feb; 13(2):73-82. PubMed ID: 14998068
[TBL] [Abstract][Full Text] [Related]
57. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache.
Dechant KL; Clissold SP
Drugs; 1992 May; 43(5):776-98. PubMed ID: 1379152
[TBL] [Abstract][Full Text] [Related]
58. Sumatriptan (oral route of administration) for acute migraine attacks in adults.
Derry CJ; Derry S; Moore RA
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD008615. PubMed ID: 22336849
[TBL] [Abstract][Full Text] [Related]
59. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.
Göbel H; Winter P; Boswell D; Crisp A; Becker W; Hauge T; Mihout B; Niewold J; Tørring J
Clin Ther; 2000 Aug; 22(8):981-9. PubMed ID: 10972634
[TBL] [Abstract][Full Text] [Related]
60. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]